FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2132006093> ?p ?o ?g. }

• W2132006093 endingPage "167" @default.
• W2132006093 startingPage "160" @default.
• W2132006093 abstract "Cognitive impairments are a core feature in schizophrenia. They impact several cognitive abilities but most importantly attention, memory and executive functions, consequently leading to great difficulties in everyday life. Most schizophrenia patients need assurance and require assistance and help from care workers, family members and friends. Family members taking care of a patient have additional daily work burden, and suffer psychological anguish and anxiety. Therefore, improving cognitive functions in schizophrenia patients is essential for the well-being of patients and their relatives. Reducing these deficits may decrease the economic burden to the health care system through lower numbers of hospital admissions and shorter hospitalisation periods, for example. Cognitive rehabilitation was developed to address the limited benefits of conventional treatments on cognitive deficits through the use of assistive technology as a means of enhancing memory and executive skills in schizophrenia patients.To provide clinicians with comprehensive knowledge on cognitive trainings, programs of remediation, and cognitive assistive technologies.Literature review. A search in the electronic databases (PubMed, EMBASE, Index Medicus) for recent articles in the last 10 years related to cognitive remediation published in any language using the words: cognitive and remediation or rehabilitation and schizophrenia, and a search for chapters in psychiatry and rehabilitation textbooks.We found 392 articles and 112 review paper mainly in English. First, we identified cognitive remediation programs that were beneficial to schizophrenia patients. Programs available in French (IPT, RECOS, and RehaCom) and others (CET, NET, CRT, NEAR, APT and CAT) were identified. In addition, since memory and executive function impairments could be present in people without schizophrenia, we reviewed inventories of cognitive assistive technologies proven to enhance cognitive skills in other populations. Finally, we present a review of recent studies testing innovative devices developed to assist schizophrenia patients.First, we found several cognitive programs proven to be effective with schizophrenia patients, but only three were validated in French. It could be useful to adapt other programs for French-speaking populations. Unfortunately, we found that very few of the existing cognitive assistive technologies are proposed to be used with schizophrenia patients. In fact, most of the available cognitive orthoses were tested primarily in people with neurological injuries (for example, various memory impairments caused by traumas), and in elderly illnesses (like Alzheimer disease). Devices for patients with mental deficits (e.g., mental retardation) were developed later, and only very recently explored for use in schizophrenia. As a result of an international collaboration between France and Canada, currently a tool called MOBUS is being tested. This technology aims at improving the autonomy of schizophrenia patients, by helping them plan and remember their daily activities. Furthermore, it encourages patient-caregiver communication, and permits monitoring patients' subjective reports of their symptoms. The use of cognitive assistive technologies is not meant to isolate patients by replacing the human element of relatives and caregivers by a machine. On the contrary, they offer a sense of security and they improve interpersonal relationships by permitting enhanced autonomy and greater self-confidence. Finally, a literature review of cognitive remediation in schizophrenia emphasizes the importance of a structured application of the technique in order for it to succeed. First, it is crucial to detect the impairments that will be targeted in each patient presenting a specific pattern of impairments. For this purpose, validated and customised neuropsychological tests are required. Then, cognitive remediation programs must be customised to each patient's needs in order to motivate the patient to participate. Finally, long-term effects must be assessed in order to verify whether reinforcement is needed. Following these steps, most of the studies show an improvement in the well-being of patients with schizophrenia. These recommendations are also suitable for the cognitive remediation programs, as for treatments with cognitive assistive devices. An important hurdle facing the advance of cognitive assistive technology programs is that different research groups work individually without a coordinated effort to improve and validate the existing programs.Schizophrenia treatments must take into account not only patients' symptoms, but also the associated cognitive deficits which constitute an important factor in their social problems. It has been shown that several cognitive remediation programs are efficient in schizophrenia. New technologies complement the benefits of such programs, and support pharmacological treatments and psychotherapies." @default.
• W2132006093 created "2016-06-24" @default.
• W2132006093 creator A5032024974 @default.
• W2132006093 creator A5071746542 @default.
• W2132006093 creator A5084324705 @default.
• W2132006093 date "2009-04-01" @default.
• W2132006093 modified "2023-09-24" @default.
• W2132006093 title "Remédiation cognitive et assistants cognitifs numériques dans la schizophrénie" @default.
• W2132006093 cites W1595925692 @default.
• W2132006093 cites W1616286551 @default.
• W2132006093 cites W1968067487 @default.
• W2132006093 cites W1972265376 @default.
• W2132006093 cites W1983134098 @default.
• W2132006093 cites W1992010020 @default.
• W2132006093 cites W1997505223 @default.
• W2132006093 cites W2001004325 @default.
• W2132006093 cites W2002836065 @default.
• W2132006093 cites W2024900319 @default.
• W2132006093 cites W2027067828 @default.
• W2132006093 cites W2094413805 @default.
• W2132006093 cites W2096714922 @default.
• W2132006093 cites W2111868689 @default.
• W2132006093 cites W2115821201 @default.
• W2132006093 cites W2119737568 @default.
• W2132006093 cites W2121790431 @default.
• W2132006093 cites W2142996855 @default.
• W2132006093 cites W2145297660 @default.
• W2132006093 cites W2147949771 @default.
• W2132006093 cites W2151763900 @default.
• W2132006093 cites W2157509275 @default.
• W2132006093 cites W2159697072 @default.
• W2132006093 cites W2160274416 @default.
• W2132006093 cites W2162231990 @default.
• W2132006093 cites W2167052106 @default.
• W2132006093 cites W2168221411 @default.
• W2132006093 cites W2168340793 @default.
• W2132006093 cites W2172039730 @default.
• W2132006093 cites W4294856087 @default.
• W2132006093 doi "https://doi.org/10.1016/j.encep.2008.02.010" @default.
• W2132006093 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19393385" @default.
• W2132006093 hasPublicationYear "2009" @default.
• W2132006093 type Work @default.
• W2132006093 sameAs 2132006093 @default.
• W2132006093 citedByCount "29" @default.
• W2132006093 countsByYear W21320060932012 @default.
• W2132006093 countsByYear W21320060932013 @default.
• W2132006093 countsByYear W21320060932014 @default.
• W2132006093 countsByYear W21320060932015 @default.
• W2132006093 countsByYear W21320060932016 @default.
• W2132006093 countsByYear W21320060932017 @default.
• W2132006093 countsByYear W21320060932018 @default.
• W2132006093 countsByYear W21320060932019 @default.
• W2132006093 countsByYear W21320060932021 @default.
• W2132006093 crossrefType "journal-article" @default.
• W2132006093 hasAuthorship W2132006093A5032024974 @default.
• W2132006093 hasAuthorship W2132006093A5071746542 @default.
• W2132006093 hasAuthorship W2132006093A5084324705 @default.
• W2132006093 hasConcept C118552586 @default.
• W2132006093 hasConcept C15744967 @default.
• W2132006093 hasConcept C169760540 @default.
• W2132006093 hasConcept C169900460 @default.
• W2132006093 hasConcept C2775968953 @default.
• W2132006093 hasConcept C2776412080 @default.
• W2132006093 hasConcept C2778818304 @default.
• W2132006093 hasConcept C558461103 @default.
• W2132006093 hasConcept C63529061 @default.
• W2132006093 hasConcept C68015696 @default.
• W2132006093 hasConcept C70410870 @default.
• W2132006093 hasConceptScore W2132006093C118552586 @default.
• W2132006093 hasConceptScore W2132006093C15744967 @default.
• W2132006093 hasConceptScore W2132006093C169760540 @default.
• W2132006093 hasConceptScore W2132006093C169900460 @default.
• W2132006093 hasConceptScore W2132006093C2775968953 @default.
• W2132006093 hasConceptScore W2132006093C2776412080 @default.
• W2132006093 hasConceptScore W2132006093C2778818304 @default.
• W2132006093 hasConceptScore W2132006093C558461103 @default.
• W2132006093 hasConceptScore W2132006093C63529061 @default.
• W2132006093 hasConceptScore W2132006093C68015696 @default.
• W2132006093 hasConceptScore W2132006093C70410870 @default.
• W2132006093 hasIssue "2" @default.
• W2132006093 hasLocation W21320060931 @default.
• W2132006093 hasLocation W21320060932 @default.
• W2132006093 hasOpenAccess W2132006093 @default.
• W2132006093 hasPrimaryLocation W21320060931 @default.
• W2132006093 hasRelatedWork W1785030990 @default.
• W2132006093 hasRelatedWork W1974416058 @default.
• W2132006093 hasRelatedWork W1989684724 @default.
• W2132006093 hasRelatedWork W2002430578 @default.
• W2132006093 hasRelatedWork W2002836065 @default.
• W2132006093 hasRelatedWork W2979992536 @default.
• W2132006093 hasRelatedWork W3159823554 @default.
• W2132006093 hasRelatedWork W36976070 @default.
• W2132006093 hasRelatedWork W4255967306 @default.
• W2132006093 hasRelatedWork W4313238644 @default.
• W2132006093 hasVolume "35" @default.
• W2132006093 isParatext "false" @default.
• W2132006093 isRetracted "false" @default.
• W2132006093 magId "2132006093" @default.

• next